D'ANDREA, EMMA
 Distribuzione geografica
Continente #
NA - Nord America 4.991
EU - Europa 469
AS - Asia 243
OC - Oceania 3
SA - Sud America 3
Totale 5.709
Nazione #
US - Stati Uniti d'America 4.987
CN - Cina 181
FI - Finlandia 111
SE - Svezia 97
DE - Germania 88
UA - Ucraina 65
GB - Regno Unito 42
SG - Singapore 32
IT - Italia 28
VN - Vietnam 16
IE - Irlanda 12
NL - Olanda 12
BE - Belgio 5
IN - India 5
CA - Canada 4
JP - Giappone 4
DK - Danimarca 3
TR - Turchia 3
AU - Australia 2
BR - Brasile 2
CH - Svizzera 1
EC - Ecuador 1
ES - Italia 1
IL - Israele 1
LI - Liechtenstein 1
MD - Moldavia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RU - Federazione Russa 1
Totale 5.709
Città #
Fairfield 721
Ann Arbor 690
Woodbridge 682
Houston 509
Jacksonville 338
Chandler 310
Cambridge 294
Ashburn 280
Wilmington 275
Seattle 240
Princeton 137
San Diego 99
Nanjing 46
Beijing 41
Helsinki 35
Boardman 33
Medford 29
Des Moines 28
Singapore 21
Hebei 17
Dong Ket 16
Shenyang 15
Dublin 12
Changsha 11
Nanchang 11
Norwalk 11
Padova 9
Guangzhou 8
Kilburn 7
Tianjin 7
Jiaxing 6
Jinan 6
London 6
Falls Church 5
Redwood City 5
Tappahannock 5
Milan 4
Waanrode 4
Copenhagen 3
Kharkiv 3
Munich 3
New York 3
Tokyo 3
Acton 2
Amsterdam 2
Borås 2
Catanzaro 2
Chicago 2
Hanover 2
Hounslow 2
Indiana 2
Islington 2
Las Vegas 2
Marshall 2
New Bedfont 2
Ningbo 2
Ogden 2
Orange 2
Rockville 2
San Francisco 2
São Paulo 2
Taiyuan 2
Zhengzhou 2
Apricena 1
Bern 1
Brussels 1
Chiswick 1
Christchurch 1
Cividate Al Piano 1
Edinburgh 1
Folkestone 1
Geislingen an der Steige 1
Genova 1
Hangzhou 1
Hefei 1
Hendon 1
Il-Madliena 1
La Spezia 1
Los Angeles 1
Manila 1
Orlando 1
Pune 1
Quito 1
Quzhou 1
Schaan 1
Suginami-ku 1
Taizhou 1
Telde 1
Treviso 1
Trivandrum 1
Walnut 1
Yellow Springs 1
Totale 5.057
Nome #
Analysis of Epstein-Barr virus (EBV) type and variant in spontaneous lymphoblastoid cells and Hu-SCID mouse tumours 171
The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy. 134
DOMINANCE OF A SINGLE EPSTEIN-BARR-VIRUS STRAIN IN SCID-MOUSE TUMORS INDUCED BY INJECTION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HEALTHY-HUMAN DONORS 126
BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from northeast Italy 118
Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation. 117
Natural history of M-MSV tumors in mice carrying endogenized Moloney leukemia virus. 115
Spontaneous lymphomas in SJL/J-(v+) mice: ecotropic and dualtropic virus expression in normal and lymphomatous tissues. 113
Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients. 111
CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment. 111
Identification of a human endogenous LTR-like sequence using HIV-1 LTR specific primers. 109
LYMPHOPROLIFERATIVE DISEASE IN HUMAN PERIPHERAL-BLOOD-MONONUCLEAR-CELL-INJECTED SCID MICE .2. ROLE OF HOST AND DONOR FACTORS IN TUMOR GENERATION 106
Reconstructing the genealogy of a BRCA1 founder mutation by phylogenetic analysis 102
Role of infectious virus expression and immune response in retrovirus-induced oncogenesis. 101
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 101
PRIMARY LYMPHOMA OF THE CENTRAL-NERVOUS-SYSTEM IN 2 CHILDREN WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME 98
Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers 98
Characterization of dualtropic type C retroviruses isolated from spontaneous non-T lymphomas of SJL/J(V+) mice. 97
UNCOUPLING OF GROWTH-INHIBITION AND DIFFERENTIATION IN DEXAMETHASONE-TREATED HUMAN RHABDOMYOSARCOMA CELLS 97
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations. 96
Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori: Scratch and win 95
Tolerance to viral antigens in Mov-13 mice carrying endogenized Moloney-murine leukemia virus. 94
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. 90
FAILURE OF B-CELLS OF CHRONIC LYMPHOCYTIC-LEUKEMIA IN PRESENTING SOLUBLE AND ALLOANTIGENS 90
Abelson murine leukemia virus-induced thymic lymphomas: transformation of a primitive lymphoid precursor. 89
Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes. 88
Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 -/- epithelial ovarian cancers 87
Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy 86
In vitro malignant progression of cells derived from Abelson murine leukaemia virus-induced thymic lymphomas. 86
Large genomic deletions inactivate the BRCA2 gene in breast cancer families 85
Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer 84
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations 83
Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status 82
B Non-Hodgkin lymphoma in a haemophilia patient with idiopathic CD4+ T-lymphocytopenia. 81
TP53 gene mutations in gastric carcinoma detected by polymerase chain reaction/single-strand conformation polymorphism analysis of archival material. 81
Pathologic findings in 200 consecutive fallopian tube specimens 80
Myosin isoform expression in rat rhabdomyosarcoma induced by Moloney murine sarcoma virus. 79
Nucleic acid sequence and oncogenic properties of the HZ2 feline sarcoma virus v-abl insert. 78
TUMORS INDUCED BY MOLONEY MURINE SARCOMA-VIRUS ARE CLONAL IN RATS, NOT CLONAL IN MICE 77
Infection of simian B lymphoblastoid cells with simian immunodeficiency virus is associated with upregulation of CD23 and CD40 cell surface markers 75
Protection from spontaneous lymphoma development in SJL/J(v+) mice neonatally injected with dualtropic SJL-151 virus. 73
Myasthenic syndrome and oligoclonal lymphocytosis: evolution into chronic lymphocytic leukemia 72
Co-existence of cutaneous T-cell lymphoma and B hairy cell leukemia 71
Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents. 71
Identification of BRCA1 and BRCA2 carriers by allele-specific gene expression (AGE) analysis 70
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 70
Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancer 67
LYMPHOPROLIFERATIVE DISEASE IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL-INJECTED SCID MICE .1. LYMPHOCYTE-T REQUIREMENT FOR B-CELL TUMOR GENERATION 65
Ovarian cancer at the BRCA era: Tube or ovary?Results of tubal sampling protocol applied to all routine cases. III Seminario CientificoCancer: Actualidad, Perspectiva y continuidadCHEMSA Clinica Hospital de Especialidades Medicas Panama (Panama) 65
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 64
Resistance to Moloney murine sarcoma virus (M-MuSV) tumor induction is associated with natural antibody production to "endogenous" Moloney leukemia virus (M-MuLV) in BALB/Mo mice. 63
The BRCA2 sequence variant IVS19+1G A leads to an aberrant transcript lacking exon 19. 62
Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families 59
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). 58
Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer 58
Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations 57
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers 55
Identification of seven new BRCA1 germline mutations in italian breast and breast/ovarian cancer families. 54
Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian canceer families. 53
INVITRO DIFFERENTIATION OF RHABDOMYOSARCOMAS INDUCED BY NICKEL OR BY MOLONEY MURINE SARCOMA-VIRUS 53
Genetics of murine sarcoma virus (MSV)--induced tumors in AKR mice: Evidence that late progressing and early regressing tumors are controlled by different gents. 51
HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: a model for a persistent "self-limiting" HIV-1 infection. 50
Chronic B-cell lymphoproliferative disease: relationship between immunophenotype and clinical stage. 48
Characterization of polysome-associated RNA from influenza virus-infected cells. 47
A CD30-POSITIVE T-CELL LINE ESTABLISHED FROM AN AGGRESSIVE ANAPLASTIC LARGE-CELL LYMPHOMA, ORIGINALLY DIAGNOSED AS HODGKINS-DISEASE 45
Hashimoto's thyroiditis and Greaves' disease associated with retroperitoneal fibrosis 44
Rediscovering the Fallopian tube at the time of BRCAmut. Three years experience on tubal sampling protocol applied to all routine cases. 43
Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma. 42
Expression of cellular oncogenes: unrearranged c-myc gene but altered promoter usage in radiation-induced thymoma. 40
Morphological and phenotypical changes in EBV positive lymphoblastoid cells infected by HIV-1. 38
TUMORI DELLA SALPINGE: NON SONO POI COSI' RARI. PROTOCOLLO DI PRELIEVI NELLA ROUTINE 36
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. 31
Ethiopatogenesis of primary hepatic cancers 31
Analysis of BRCA gene mutations in breast/ovarian cancer families in Veneto. 29
Genetic counselling for breast/ovarian cancer families: the Padova experience. 27
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. 23
Molecular profile of Epstein-Barr virus (EBV) in human immunodeficiency virus (HIV)-related lymphoadenopathies and lymphomas. 21
Totale 5.717
Categoria #
all - tutte 18.584
article - articoli 17.851
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 95
Totale 36.530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019152 0 0 0 0 0 0 0 0 0 0 0 152
2019/20201.225 187 55 30 81 128 101 116 144 129 124 68 62
2020/2021657 43 53 46 46 19 40 33 106 124 46 60 41
2021/20221.058 19 131 151 85 31 68 61 122 21 19 159 191
2022/2023649 165 63 14 85 86 98 0 45 61 2 23 7
2023/2024180 12 31 39 20 11 4 12 13 3 2 32 1
Totale 5.717